Data Collective IV GP, LLC
- SEC CIK
- 0001664974
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 5
- −1 vs. Q2 2023
- Portfolio value
- $105.7M
- −$29.4M (−21.8%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 9,681,280 | $47.1M | 44.5% | −920,001−8.7% | Reduced | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 5,941,120 | $45.4M | 43.0% | 00.0% | Unchanged | History |
| RKLBRocket Lab Corp | COM | 2,929,350 | $12.8M | 12.1% | 00.0% | Unchanged | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 100,349 | $314.1K | 0.3% | −10.0% | Reduced | History |
| ROIVRoivant Sciences Ltd. | SHS | 3,875 | $45.3K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2023 (1)
Positions held at the end of Q2 2023 that are gone from this filing.